Posted inBusiness News
Silexion Therapeutics Announces Pricing of $5.0 Million Public Offering By Investing.com
Cayman Islands, January 15, 2025 -- Silexion Therapeutics Corp (NASDAQ: SLXN) (Silexion Therapeutics or the Company), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the…